The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Bicara Therapeutics Inc’s stock clocked out at $12.97, down -1.22% from its previous closing price of $13.13. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 0.73 million shares were traded.
Ratios:
To gain a deeper understanding of BCAX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.93 and its Current Ratio is at 27.93. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 17, 2025, initiated with a Underweight rating and assigned the stock a target price of $8.
On February 06, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $31.
On December 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.H.C. Wainwright initiated its Buy rating on December 06, 2024, with a $42 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Meisner Lara sold 79,146 shares for $12.90 per share. The transaction valued at 1,021,211 led to the insider holds 0 shares of the business.
LARA S. MEISNER bought 79,146 shares of BCAX for $1,056,599 on Mar 14 ’25. On Sep 16 ’24, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 1,833,000 shares for $18.00 each. As a result, the insider paid 32,994,000 and bolstered with 4,303,418 shares of the company.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $28.09, while it has fallen to a 52-week low of $8.91. The 50-Day Moving Average of the stock is -1.03%, while the 200-Day Moving Average is calculated to be -23.76%.
Shares Statistics:
A total of 54.44M shares are outstanding, with a floating share count of 30.96M. Insiders hold about 43.23% of the company’s shares, while institutions hold 55.91% stake in the company.
